NO20024802L - Terapeutisk anvendbare nye salter av CCK-inhibitorer, fremgangsmÕte for fremstilling derav og farmasöytiske preparaterinneholdende disse - Google Patents
Terapeutisk anvendbare nye salter av CCK-inhibitorer, fremgangsmÕte for fremstilling derav og farmasöytiske preparaterinneholdende disseInfo
- Publication number
- NO20024802L NO20024802L NO20024802A NO20024802A NO20024802L NO 20024802 L NO20024802 L NO 20024802L NO 20024802 A NO20024802 A NO 20024802A NO 20024802 A NO20024802 A NO 20024802A NO 20024802 L NO20024802 L NO 20024802L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- methods
- pharmaceutical preparations
- preparations containing
- new salts
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0001417A HUP0001417A2 (hu) | 2000-04-07 | 2000-04-07 | Gyógyászatilag alkalmazható új sók, eljárás előállításukra és azokat tartalmazó gyógyászati készítmények |
PCT/HU2001/000039 WO2001077108A1 (en) | 2000-04-07 | 2001-04-04 | Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20024802L true NO20024802L (no) | 2002-10-04 |
NO20024802D0 NO20024802D0 (no) | 2002-10-04 |
Family
ID=89978239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024802A NO20024802D0 (no) | 2000-04-07 | 2002-10-04 | Terapeutisk anvendbare nye salter av CCK-inhibitorer, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende disse |
Country Status (21)
Country | Link |
---|---|
US (1) | US20030176475A1 (no) |
EP (1) | EP1274707A1 (no) |
JP (1) | JP2003530396A (no) |
KR (1) | KR20020084296A (no) |
CN (1) | CN1420885A (no) |
AU (1) | AU2001248656A1 (no) |
BG (1) | BG107219A (no) |
BR (1) | BR0109890A (no) |
CA (1) | CA2405004A1 (no) |
CZ (1) | CZ20023671A3 (no) |
EA (1) | EA200201076A1 (no) |
EE (1) | EE200200582A (no) |
HU (2) | HUP0001417A2 (no) |
IL (1) | IL152005A0 (no) |
IS (1) | IS6577A (no) |
MX (1) | MXPA02009887A (no) |
NO (1) | NO20024802D0 (no) |
PL (1) | PL362650A1 (no) |
SK (1) | SK15052002A3 (no) |
WO (1) | WO2001077108A1 (no) |
ZA (1) | ZA200207969B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY142390A (en) | 2002-05-22 | 2010-11-30 | Glaxosmithkline Llc | 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
US7164383B2 (en) | 2002-09-25 | 2007-01-16 | The Board Of Regents Of The University Of Oklahoma | Navigation system using locally augmented GPS |
ECSP077628A (es) | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
EP3127427B1 (en) | 2009-05-29 | 2020-01-08 | Novartis Ag | Methods of administration of thrombopoietin agonist compounds |
ES2926790T3 (es) * | 2016-05-04 | 2022-10-28 | Youngene Therapeutics Co Ltd | Solvato de dietilamina del inhibidor del transportador de sodio-glucosa, y método de preparación y aplicación del mismo |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4970713A1 (es) * | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
-
2000
- 2000-04-07 HU HU0001417A patent/HUP0001417A2/hu unknown
-
2001
- 2001-04-04 JP JP2001575581A patent/JP2003530396A/ja not_active Withdrawn
- 2001-04-04 EE EEP200200582A patent/EE200200582A/xx unknown
- 2001-04-04 EA EA200201076A patent/EA200201076A1/ru unknown
- 2001-04-04 PL PL01362650A patent/PL362650A1/xx not_active Application Discontinuation
- 2001-04-04 BR BR0109890-0A patent/BR0109890A/pt not_active IP Right Cessation
- 2001-04-04 HU HU0204476A patent/HUP0204476A2/hu unknown
- 2001-04-04 WO PCT/HU2001/000039 patent/WO2001077108A1/en not_active Application Discontinuation
- 2001-04-04 AU AU2001248656A patent/AU2001248656A1/en not_active Abandoned
- 2001-04-04 KR KR1020027013375A patent/KR20020084296A/ko not_active Application Discontinuation
- 2001-04-04 EP EP01921689A patent/EP1274707A1/en not_active Withdrawn
- 2001-04-04 US US10/240,698 patent/US20030176475A1/en not_active Abandoned
- 2001-04-04 CA CA002405004A patent/CA2405004A1/en not_active Abandoned
- 2001-04-04 MX MXPA02009887A patent/MXPA02009887A/es unknown
- 2001-04-04 CZ CZ20023671A patent/CZ20023671A3/cs unknown
- 2001-04-04 CN CN01807475A patent/CN1420885A/zh active Pending
- 2001-04-04 SK SK1505-2002A patent/SK15052002A3/sk unknown
- 2001-04-04 IL IL15200501A patent/IL152005A0/xx unknown
-
2002
- 2002-10-02 IS IS6577A patent/IS6577A/is unknown
- 2002-10-03 ZA ZA200207969A patent/ZA200207969B/en unknown
- 2002-10-04 NO NO20024802A patent/NO20024802D0/no not_active Application Discontinuation
- 2002-10-24 BG BG107219A patent/BG107219A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
US20030176475A1 (en) | 2003-09-18 |
AU2001248656A1 (en) | 2001-10-23 |
ZA200207969B (en) | 2004-02-10 |
HUP0204476A2 (en) | 2003-05-28 |
BR0109890A (pt) | 2003-06-03 |
MXPA02009887A (es) | 2003-06-17 |
EP1274707A1 (en) | 2003-01-15 |
EA200201076A1 (ru) | 2003-04-24 |
PL362650A1 (en) | 2004-11-02 |
BG107219A (bg) | 2003-05-30 |
SK15052002A3 (sk) | 2003-05-02 |
HU0001417D0 (en) | 2000-06-28 |
JP2003530396A (ja) | 2003-10-14 |
CZ20023671A3 (cs) | 2003-05-14 |
WO2001077108A1 (en) | 2001-10-18 |
EE200200582A (et) | 2004-04-15 |
IL152005A0 (en) | 2003-04-10 |
KR20020084296A (ko) | 2002-11-04 |
HUP0001417A2 (hu) | 2002-12-28 |
IS6577A (is) | 2002-10-02 |
NO20024802D0 (no) | 2002-10-04 |
CN1420885A (zh) | 2003-05-28 |
CA2405004A1 (en) | 2001-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20032726L (no) | Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav | |
NO20012983D0 (no) | Nye malonsyrederivater, fremgangsmåter for fremstilling derav, og farmasöytiske preparater inneholdende disse (inhiberingav faktor Xa-aktivitet) | |
NO20032734L (no) | Nye 1,2-difenylazetidinoner, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og anvendelse av disse forbehandling av sykdommer fra lipidstoffskiftet | |
NO20015797D0 (no) | Indazolforbindelser og farmasöytiske forbindelser for inhibering av proteinkinaser, og fremgangsmåter til anvendelsederav | |
NO20051645L (no) | Nye aminoindozolderivater som medisin og farmakologiske preparater inneholdende disse | |
NO20032733L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
NO20021599L (no) | Nye farmasöytiske sammensetninger av anti-tuberkulose legemidler og fremgangsmåte for deres fremstilling | |
DK1523488T3 (da) | Nye thiophenglycosidderivater, fremgangsmåder til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
NO996433L (no) | Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav | |
NO20031694L (no) | Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament | |
NO20024176L (no) | Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling | |
NO20040268L (no) | Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen | |
DK1674456T3 (da) | Nye 1,4-benzothiazepin-1,1-dioxid-derivater med forbedrede egenskaber, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
NO20023400D0 (no) | Nye forbindelser med lipid- og kolesterolnedsettende virkning, fremgangsmåte ved deres fremstilling og farmasöytiskpreparat | |
DK1495023T3 (da) | Hidtil ukendte derivater af 1,2,3-substitueret indolizin, FGF-inhibitorer, fremgangsmåde for fremstilling og farmaceutiske sammensætninger indeholdende disse | |
NO20026212D0 (no) | Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen | |
NO20042272L (no) | Farmasoytiske blandinger og fremgangsmater for administrering av EP2-reseptor selektive agonister | |
NO20023662L (no) | Nye heterocykliske derivater, fremgangsmåte ved fremstilling og farmasöytiske sammensetninger inneholdende det samme | |
NO20024802L (no) | Terapeutisk anvendbare nye salter av CCK-inhibitorer, fremgangsmÕte for fremstilling derav og farmasöytiske preparaterinneholdende disse | |
NO20015058D0 (no) | Nye ribose-substituerte aromatiske amider, metode for fremstilling, og andvendelse derav som medikamenter | |
NO20030618L (no) | Fremgangsmåte til fremstilling av peptidsalter, deres anvendelse, og farmasöytiske preparater som inneholder disse peptidsaltene | |
NO20014632L (no) | Nye morfolinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende de nevnte derivater | |
NO20031108L (no) | Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet | |
NO20023316D0 (no) | Ny fremgangsmåte for fremstilling av a-(2-4-disulfofenyl)-N- tertbutylnitron og farmasöytisk akseptable salter derav | |
NO20020777D0 (no) | Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |